drugset
drugset / Trial / NCT01283698

Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis

NCT01283698 ↗

Phase 2 Completed 20 enrolled Almirall, S.A.
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the study is to intra-individually compare the dose-related efficacy of LAS41004 in a Psoriasis Plaque Test (PPT)

Timeline

Start
2011-01
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject LAS41004 Unknown — —

Indications

psoriasis